AbbVie and Lilly leave U.K. drug pricing deal (NYSE:ABBV)

Hands ripping contract agreement document


AbbVie (NYSE:ABBV) and Eli Lilly (NYSE:LLY) have left a voluntary drug pricing agreement between the pharma industry and the U.K. government, under which there were limits to the growth of branded medicine sales to the country’s National

Source link

5 Trading strategies to make money

Looking to boost your trading profits?

Get you copy of our FREE Ebook Now !!!